作者：
Cohen, E. E. W. [1]
;
Licitra, L. F. [2]
;
Burtness, B. [3]
;
Fayette, J. [4]
;
Gauler, T. [5]
;
Clement, P. M. [6]
;
Grau, J. J. [7]
;
del Campo, J. M. [8]
;
Mailliez, A. [9]
;
Haddad, R. I. [10]
;
Vermorken, J. B. [11]
;
Tahara, M. [12]
;
Guigay, J. [13]
;
Geoffrois, L. [14]
;
Merlano, M. C. [15]
;
Dupuis, N. [16]
;
Kraemer, N. [17]
;
Cong, X. J. [18]
;
Gibson, N. [19]
;
Solca, F. [20]
;
Ehrnrooth, E. [21]
;
Machiels, J. -P. H. [22]
作者单位：
Inst Canc Lorraine, Dept Med Oncol, Vandoeuvre Les Nancy, France
[1]
Boehringer Ingelheim RCV GmbH & Co KG, Pharmacol & Translat Res, Vienna, Austria
[2]
Clin Univ St Luc, Serv Oncol Med, Inst Roi Albert 2, Brussels, Belgium
[3]
Univ Calif San Diego, Moores Canc Ctr, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA
[4]
Danmark A S, Boehringer Ingelheim, TA Oncol, Ballerup, Denmark
[5]
Antwerp Univ Hosp, Dept Med Oncol, Edegem, Belgium
[6]
Yale Univ, Sch Med, Dept Med Oncol, New Haven, CT USA
[7]
Ctr Oscar Lambret, Oncol Dept Mastol, Lille, France
[8]
Biodesix Inc, Boulder, CO USA
[9]
Vall Hebron Univ Hosp Barcelona, Med Oncol Dept, Barcelona, Spain
[10]
Boehringer Ingelheim Pharmaceut Inc, Biometr & Data Management, 90 E Ridge POB 368, Ridgefield, CT
[11]
Fdn IRCCS, Dept Med Oncol, Ist Nazl Tumori, Milan, Italy
[12]
Leon Berard Ctr, Dept Med, Lyon, France
[13]
Univ Barcelona, Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain
[14]
FHU OncoAge, Ctr Antoine Lacassagne, Dept Med Oncol, Nice, France
[15]
Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[16]
Staburo GmbH, Munich, Germany
[17]
Natl Canc Ctr Hosp East, Dept Head & Neck Med Oncol, Kashiwa, Chiba, Japan
[18]
Boehringer Ingelheim Pharma GmbH & Co KG, Translat Med & Clin Pharmacol, Biberach, Germany
[19]
Azienda Osped Santa Croce & Carle, Dept Med Oncol, Cuneo, Italy
[20]
Katholieke Univ Leuven, Leuven Canc Inst, Dept Oncol, Leuven, Belgium
[21]
Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Med, Essen, Germany
[22]
发布时间
2018-05-11
换一批
换一批
